1
项与 CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR(HighPass Bio) 相关的临床试验Phase I Study of Adoptive Immunotherapy With CD8+ and CD4+ Memory T Cells Transduced to Express an HA-1-Specific T Cell Receptor (TCR) for Children and Adults With Recurrent Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
This phase I trial studies the side effects and best dose of CD4+ and CD8+ HA-1 T cell receptor (TCR) (HA-1 T TCR) T cells in treating patients with acute leukemia that persists, has come back (recurrent) or does not respond to treatment (refractory) following donor stem cell transplant. T cell receptor is a special protein on T cells that helps them recognize proteins on other cells including leukemia. HA-1 is a protein that is present on the surface of some peoples' blood cells, including leukemia. HA-1 T cell immunotherapy enables genes to be added to the donor cells to make them recognize HA-1 markers on leukemia cells.
100 项与 CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR(HighPass Bio) 相关的临床结果
100 项与 CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR(HighPass Bio) 相关的转化医学
100 项与 CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR(HighPass Bio) 相关的专利(医药)
100 项与 CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR(HighPass Bio) 相关的药物交易